WAVE LIFE SCIENCES LTD. Income Taxes Paid
WAVE LIFE SCIENCES LTD. (WVE) reported Income Taxes Paid of $438.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2018-11-09
- WAVE LIFE SCIENCES LTD. income taxes paid, net for the quarter ending 2018-09-30 was $16.00K, a 45.45% increase year-over-year.
- WAVE LIFE SCIENCES LTD. income taxes paid, net for the quarter ending 2018-06-30 was $108.00K, a 40.66% decline year-over-year.
- WAVE LIFE SCIENCES LTD. income taxes paid, net for the quarter ending 2018-03-31 was $314.00K, a 1644.44% increase year-over-year.
- WAVE LIFE SCIENCES LTD. income taxes paid, net for the quarter ending 2017-12-31 was -$222.00K.
- WAVE LIFE SCIENCES LTD. income taxes paid, net for fiscal 2017 was -$11.00K, a 101.99% decline from fiscal 2016.
- WAVE LIFE SCIENCES LTD. income taxes paid, net for fiscal 2016 was $554.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2018-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $124.00K derived: sum of 2 quarters · filed 2018-11-09 | $438.00K 10-Q · filed 2018-11-09 | $216.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $422.00K 10-Q · filed 2018-08-09 | $200.00K derived: sum of 3 quarters · filed 2018-08-09 | $211.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-03-31 | $314.00K 10-Q · filed 2018-05-09 | $92.00K derived: sum of 2 quarters · filed 2018-05-09 | $103.00K derived: sum of 3 quarters · filed 2018-11-09 | $285.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-12-31 | -$222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$211.00K derived: sum of 2 quarters · filed 2018-11-09 | -$29.00K derived: sum of 3 quarters · filed 2018-11-09 | -$11.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $193.00K derived: sum of 2 quarters · filed 2018-11-09 | $211.00K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $200.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $18.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $554.00K 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |